Current and Future Hepatitis C Therapies
Author:
Publisher
Elsevier BV
Subject
General Medicine
Reference120 articles.
1. Hepatitis C: magnitude of the problem;Rakela;Liver Transpl,2002
2. The natural history of compensated cirrhosis due to hepatitis C virus: A 17-year cohort study of 214 patients;Sangiovanni;Hepatology,2006
3. Impact of HCV infection: projections into the next century;Davis;Hepatology,1998
4. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome;Choo;Science,1989
5. Treatment of chronic non-A, non-B hepatitis with recombinant human alpha interferon. A preliminary report;Hoofnagle;N Engl J Med,1986
Cited by 22 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Molecular modeling and docking revealed superiority of IDX-184 as HCV polymerase inhibitor;Future Virology;2017-07
2. IDX-184 is a superior HCV direct-acting antiviral drug: a QSAR study;Medicinal Chemistry Research;2016-03-04
3. 2′-Methylguanosine Prodrug (IDX-184), Phosphoramidate Prodrug (Sofosbuvir), Diisobutyryl Prodrug (R7128) Are Better Than Their Parent Nucleotides and Ribavirin in Hepatitis C Virus Inhibition: A Molecular Modeling Study;Journal of Computational and Theoretical Nanoscience;2015-03-01
4. Assessment of health-related quality of life and how it predicts the outcome of pegylated interferon and ribavirin therapy for chronic hepatitis C;Journal of Gastroenterology and Hepatology;2014-01-27
5. Restoration of Type I Interferon Expression by Heme and Related Tetrapyrroles Through Inhibition of NS3/4A Protease;The Journal of Infectious Diseases;2013-07-29
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3